Signal active
Investment Firm
Overview
Modi Ventures is a Texas-based investment firm investing in fund managers and founders building companies shaping the future of humanity. The company's primary investment focus is into disruptive and emerging AI and Medical technology applications. Investments in successful funds include Khosla Ventures, Section 32, Artis Ventures, Draper Associates and Antler Global. Direct investments include, Starling Medicine and Cyberdontics. For more information please visit www.modivc.com.
Highlights
2022
Information Technology
1-10
12
1
undefined
Early Stage Venture, Late Stage Venture, Seed
Fund Of Funds, Venture Capital
Location
Houston, Texas, United States, North America
Contact Information
Social
Profile Resume
Modi Ventures, established in 2022 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Biopharma, Genetics, Financial Services, Venture Capital, Finance, Business Development, Data Governance, Health Care, Medical. Their recent investments include Latus Bio, 8VC, Gaingels, The Children's Hospital of Philadelphia, DCVC Bio. The highest investment round they participated in was $67.7B. Among their most notable exits are Latus Bio and 8VC. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
12
4
1
undefined
Investments
12
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Sep 28, 2023 | Harbinger Health | Biotechnology | 140.0M |
Mar 05, 2024 | Tiny Health | Biotechnology | 8.5M |
Apr 22, 2024 | - | - | 40.0M |
May 02, 2024 | Latus Bio | Biotechnology | 54.0M |
Exits
0
Funding Timeline
12
0
1
Funding Rounds
12
Modi Ventures has raised 12 rounds. Their latest funding was raised on May 02, 2024 from a Series A - Latus Bio round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Sep 28, 2023 | Series B - Harbinger Health | - | 140.0M | - |
Mar 05, 2024 | Series A - Tiny Health | - | 8.5M | - |
Apr 22, 2024 | Series A - Rubedo Life Sciences | - | 40.0M | - |
May 02, 2024 | Series A - Latus Bio | - | 54.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
May 02, 2024
Latus Bio raised $54000000 on 2024-05-02 in Series A
Funding Round
Apr 22, 2024
Rubedo Life Sciences raised $40000000 on 2024-04-22 in Series A
Funding Round
Mar 05, 2024
Tiny Health raised $8500000 on 2024-03-05 in Series A
Funding Round
Sep 28, 2023
Harbinger Health raised $140000000 on 2023-09-28 in Series B
Funding Round
Sep 18, 2023
Unnatural Products raised an undisclosed amount on 2023-09-18 in Series A